Aktuelle Aussendungen (52 Treffer in 60 Monaten)
Nächste Seite
Impact of Early Insulin Initiation on Glycemic Control in Asian People with Type 2 Diabetes
OTE0007 | 5. Dez. 2011, 14:14 | Channel: Wirtschaft | Aussender: sanofi-aventis Group
Oral Therapy Teriflunomide (Aubagio?(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis
OTE0001 | 20. Okt. 2011, 08:05 | Channel: Wirtschaft | Aussender: sanofi-aventis Group
Investigational Oral Multiple Sclerosis Therapy Teriflunomide (Aubagio?(*)) Significantly Reduced Relapse Rate, Disability Progression and Disease Activity
OTE0001 | 6. Okt. 2011, 07:04 | Channel: Wirtschaft | Aussender: sanofi-aventis Group
More Patients with Type 2 Diabetes Reach HbA[1c] Target with Apidra® on top of Lantus® Than with Twice-daily Aspart Premixed Insulin
OTE0004 | 12. Sept. 2011, 13:03 | Channel: Wirtschaft | Aussender: sanofi-aventis Group
Sanofi Announces Nursing Recognition Program to Help Turn Caring Ideas Into Reality
OTE0015 | 9. Aug. 2011, 14:57 | Channel: Wirtschaft | Aussender: sanofi-aventis Group
Sanofi Pasteur and Merck Vaccines Appoint Dr Jean-Paul Kress, as President of Sanofi Pasteur MSD
OTE0005 | 7. Juli 2011, 18:18 | Channel: Wirtschaft | Aussender: sanofi-aventis Group
New Data Shows Lantus® Activation of Insulin Receptor Comparable to Human Insulin
OTE0002 | 27. Juni 2011, 07:06 | Channel: Wirtschaft | Aussender: sanofi-aventis Group
Lantus®/Apidra® SoloSTAR® Help to Improve Patient Satisfaction
OTE0001 | 27. Juni 2011, 07:04 | Channel: Wirtschaft | Aussender: sanofi-aventis Group
Sanofi Pasteur Supports Polio Eradication at First International Stock Exchange Event
OTE0006 | 23. Feb. 2011, 10:56 | Channel: Wirtschaft | Aussender: sanofi-aventis Group
Sanofi Pasteur and International Vaccine Institute Partner Against Dengue
OTE0004 | 21. Feb. 2011, 14:04 | Channel: Wirtschaft | Aussender: sanofi-aventis Group
Sanofi-aventis Partners in European Atrial Fibrillation Research Consortium
OTE0005 | 5. Nov. 2010, 09:06 | Channel: Wirtschaft | Aussender: sanofi-aventis Group
Sanofi Pasteur's Dengue Vaccine in Final Stage of Clinical Development
OTE0002 | 4. Nov. 2010, 07:03 | Channel: Wirtschaft | Aussender: sanofi-aventis Group
Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis
OTE0002 | 26. Okt. 2010, 07:03 | Channel: Wirtschaft | Aussender: sanofi-aventis Group
Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients
OTE0001 | 15. Okt. 2010, 09:19 | Channel: Wirtschaft | Aussender: sanofi-aventis Group
Sanofi-aventis: Adding Lantus(R) to Oral Antidiabetic Drug Therapy Further Reduced Blood Sugar in Patients With Type 2 Diabetes
OTE0007 | 20. Sept. 2010, 12:09 | Channel: Wirtschaft | Aussender: sanofi-aventis Group
